Tackling some of the biggest global challenges – from respiratory health in the face of climate change to fighting big...
Screening after sleep studies will reveal primary aldosteronism People with both hypertension and obstructive sleep apnoea (OSA) should be routinely...
An update of the Global Strategy for Asthma Management and Prevention has adopted a two-track approach for treatment of adults and...
Reduced sputum microbiome diversity is associated with greater disease severity in bronchiectasis, according to a new prospective study. It was...
Three new severe asthma phenotypes have been identified in one of the largest registry analyses of patients with the condition....
Research will continue to give hope in lung disease Lung Foundation Australia has launched its Hope Research Fund with a...
Mepolizumab reduces nasal polyp size and obstruction in patients with severe chronic rhinosinusitis, results from a large international study suggest....
Lack of knowledge, misinformation, and social stigma about opioids are some of the major barriers to their effective use in...
CFTR modulator registered by the TGA Trikafta has been registered by the TGA for the treatment of cystic fibrosis in...
Patients with severe asthma experience significant improvements in quality-of-life and participation in life with add-on monoclonal antibody therapies but there’s...
Enter your email address and we’ll email you a link to reset your password.
Email
